Table of Contents
Biotechnology Research International
Volume 2014, Article ID 319397, 7 pages
http://dx.doi.org/10.1155/2014/319397
Research Article

Antidepressant Fluoxetine Modulates the In Vitro Inhibitory Activity of Buffalo Brain Cystatin: A Thermodynamic Study Using UV and Fluorescence Techniques

Department of Biochemistry, Faculty of Life Sciences Aligarh Muslim University, Aligarh 202002, India

Received 7 November 2013; Revised 29 April 2014; Accepted 6 May 2014; Published 24 July 2014

Academic Editor: Goetz Laible

Copyright © 2014 Fakhra Amin and Bilqees Bano. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Turk and B. Turk, “Lysosomal cysteine proteases and their protein inhibitors: recent developments,” Acta Chimica Slovenica, vol. 55, no. 4, pp. 727–738, 2008. View at Google Scholar · View at Scopus
  2. B. Turk, A. Ritonja, I. Björk, V. Stoka, I. Dolenc, and V. Turk, “Identification of bovine stefin A: a novel protein inhibitor of cysteine proteinases,” FEBS Letters, vol. 360, no. 2, pp. 101–105, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Krizaj, B. Turk, and V. Turk, “The complete primary structure of bovine stefin B,” FEBS Letters, vol. 298, no. 2-3, pp. 237–239, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Turk, I. Krizaj, B. Kralj et al., “Bovine stefin C, a new member of the stefin family,” The Journal of Biological Chemistry, vol. 268, no. 10, pp. 7323–7329, 1993. View at Google Scholar · View at Scopus
  5. D. Silva, C. M. Cortez, and S. R. Louro, “Chlorpromazine interactions to sera albumins. A study by the quenching of fluorescence,” Spectrochimica Acta A: Molecular and Biomolecular Spectroscopy, vol. 60, no. 5, pp. 1215–1223, 2004. View at Google Scholar
  6. B. Huang, G. L. Zou, and T. M. Yang, “Studies on the interaction between adriamycin and bovine serum albumin,” Acta Chimica Sinica, vol. 60, no. 10, pp. 1867–1871, 2002. View at Google Scholar · View at Scopus
  7. B. P. Kamat and J. Seetharamappa, “In vitro study on the interaction of mechanism of tricyclic compounds with bovine serum albumin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 35, no. 3, pp. 655–664, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Seedher, “In vitro study of the mechanism of interaction of trifluoperazine dihydrochloride with bovine serum albumin,” Indian Journal of Pharmaceutical Sciences, vol. 62, no. 1, pp. 16–20, 2000. View at Google Scholar · View at Scopus
  9. N. Seedher and S. Bhatia, “Complexation of cox-2 inhibitors with bovine serum albumin: interaction mechanism,” Pharmaceutical Development and Technology, vol. 14, no. 4, pp. 343–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. B. C. Channu, H. N. Kalpana, G. B. Eregowda, C. Dass, P. J. Houghton, and K. N. Thimmaiah, “Interaction of substituted phenoxazine chemosensitizers with bovine serum albumin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 4, pp. 775–785, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. S. N. Khan, B. Islam, M. R. Rajeswari, H. Usmani, and A. U. Khan, “Interaction of anesthetic supplement thiopental with human serum albumin,” Acta Biochimica Polonica, vol. 55, no. 2, pp. 399–409, 2008. View at Google Scholar · View at Scopus
  12. U. Kragh-Hansen, “Molecular aspects of ligand binding to serum albumin.,” Pharmacological Reviews, vol. 33, no. 1, pp. 17–53, 1981. View at Google Scholar · View at Scopus
  13. J. N. Tian, J. Q. Liu, J. Y. Zhang, Z. D. Hu, and X. G. Chen, “Fluorescence studies on the interactions of barbaloin with bovine serum albumin,” Chemical and Pharmaceutical Bulletin, vol. 51, no. 5, pp. 579–582, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Sereikaite and V. A. Bumelis, “Congo red interaction with α-proteins,” Acta Biochimica Polonica, vol. 53, no. 1, pp. 87–92, 2006. View at Google Scholar · View at Scopus
  15. S. N. Khan, B. Islam, and A. U. Khan, “Probing midazolam interaction with human serum albumin and its effect on structural state of protein,” International Journal of Integrative Biology, vol. 2, pp. 102–112, 2007. View at Google Scholar
  16. “Prozac Pharmacology, Pharmacokinetics, Studies, Metabolism,” RxList.com, 2007, http://www.rxlist.com/cgi/generic/fluoxetine_cp.htm.
  17. R. J. Leo, “Movement disorders associated with the serotonin selective reuptake inhibitors,” Journal of Clinical Psychiatry, vol. 57, no. 10, pp. 449–454, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. P. E. Gerber and L. D. Lynd, “Selective serotonin-reuptake inhibitor-induced movement disorders,” The Annals of Pharmacotherapy, vol. 32, no. 6, pp. 692–698, 1998. View at Google Scholar
  19. C. F. Caley, “Extrapyramidal reactions and the selective serotonin-reuptake inhibitors,” Annals of Pharmacotherapy, vol. 31, no. 12, pp. 1481–1489, 1997. View at Google Scholar · View at Scopus
  20. F. Amin, A. Khan, J. S. Rizvi, and B. Bano, “Purification and characterization of buffalo brain cystatin,” Protein and Peptide Letters, vol. 18, no. 2, Article ID 21054269, pp. 210–218, 2011. View at Google Scholar
  21. X. Feng, Z. Lin, L. Yang, C. Wang, and C. Bai, “Investigation of the interaction between acridine orange and bovine serum albumin,” Talanta, vol. 47, no. 5, pp. 1223–1229, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Gao, L. Lei, J. Liu, Q. Kong, X. Chen, and Z. Hu, “The study on the interaction between human serum albumin and a new reagent with antitumour activity by spectrophotometric methods,” Journal of Photochemistry and Photobiology A, vol. 167, no. 2-3, pp. 213–221, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kunitz, “Crystalline soybean trypsin inhibitor II. General properties,” The Journal of General Physiology, vol. 30, pp. 291–310, 1947. View at Google Scholar
  24. F. L. Cui, J. Fan, J. P. Li, and Z. D. Hu, “Interactions between 1-benzoyl-4-p-chlorophenyl thiosemicarbazide and serum albumin: investigation by fluorescence spectroscopy,” Bioorganic & Medicinal Chemistry, vol. 12, no. 1, pp. 151–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-J. Hu, Y. Liu, J.-B. Wang, X.-H. Xiao, and S.-S. Qu, “Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 36, no. 4, pp. 915–919, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Hwang, V. Stoka, V. Turk, and V. Y. H. Hook, “The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition,” Biochemistry, vol. 44, no. 21, pp. 7757–7767, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Shaw, S. Mohanty, A. Colic, V. Stoka, and V. Turk, “The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones: comparison with the inhibition of cathepsin L and calpain,” FEBS Letters, vol. 334, no. 3, pp. 340–342, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Leary, D. Larsen, H. Watanabe, and E. Shaw, “Diazomethyl ketone substrate derivatives as active-site-directed inhibitors of thiol proteases. Papain,” Biochemistry, vol. 16, no. 26, pp. 5857–5861, 1977. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Wikstrom, H. Kirschke, S. Stone, and E. Shaw, “The properties of peptidyl diazoethanes and chloroethanes as protease inactivators,” Archives of Biochemistry and Biophysics, vol. 270, no. 1, pp. 286–293, 1989. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Barrett, A. Kembhavi, M. A. Brown et al., “L-trans-epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L,” Biochemical Journal, vol. 201, no. 1, pp. 189–198, 1982. View at Google Scholar
  31. K. Matsumoto, K. Mizoue, K. Kitamura, W. C. Tse, C. P. Huber, and T. Ishida, “Structural basis of inhibition of cysteine proteases by E-64 and its derivatives,” Peptide Science, vol. 51, no. 1, pp. 99–107, 1999. View at Google Scholar
  32. H. G. Bernstein, H. Kirschke, B. Wiederanders, K. H. Pollak, A. Zipress, and A. Rinne, “The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease,” Molecular and Chemical Neuropathology, vol. 27, no. 3, pp. 225–247, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Sotiropoulou, A. Anisowicz, and R. Sager, “Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer,” The Journal of Biological Chemistry, vol. 272, no. 2, pp. 903–910, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Trabandt, R. E. Gay, H. Fassbender, and S. Gay, “Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 34, no. 11, pp. 1444–1451, 1991. View at Google Scholar · View at Scopus
  35. J.-M. Delaisse, P. Ledent, and G. Vaes, “Collagenolytic cysteine proteinases of bone tissue: cathepsin B, (pro) cathepsin L and a cathepsin L-like 70 kDa proteinase,” Biochemical Journal, vol. 279, no. 1, pp. 167–174, 1991. View at Google Scholar · View at Scopus
  36. A. Kabanda, E. Goffin, A. Bernard, R. Lauwerys, and C. van Ypersele de Strihou, “Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis,” Kidney International, vol. 48, no. 6, pp. 1946–1952, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Servais, P. Giral, M. Bernard, E. Bruckert, G. Deray, and C. Isnard Bagnis, “Is serum cystatin-C a reliable marker for metabolic syndrome?” American Journal of Medicine, vol. 121, no. 5, pp. 426–432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. D. T. Wong, F. P. Bymaster, J. S. Horng, and B. B. Molloy, “A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine,” Journal of Pharmacology and Experimental Therapeutics, vol. 193, no. 3, pp. 804–811, 1975. View at Google Scholar · View at Scopus
  39. D. T. Wong and F. P. Bymaster, “The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p chloroamphetamine and 6 hydroxydopamine in the rat brain,” Research Communications in Chemical Pathology and Pharmacology, vol. 15, no. 2, pp. 221–231, 1976. View at Google Scholar · View at Scopus
  40. P. Stark and C. D. Hardison, “A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder,” Journal of Clinical Psychiatry, vol. 46, no. 3, pp. 53–58, 1985. View at Google Scholar · View at Scopus
  41. M. O. Carruba, S. Ricciardi, P. Spano, and P. Mantegazza, “Dopaminergic and serotoninergic anorectics differentially antagonize insulin- and 2-DG-induced hyperphagia,” Life Sciences, vol. 36, no. 18, pp. 1739–1749, 1985. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Ahmad, M. K. A. Khan, S. K. Haq, and R. H. Khan, “Intermediate formation at lower urea concentration in 'B' isomer of human serum albumin: a case study using domain specific ligands,” Biochemical and Biophysical Research Communications, vol. 314, no. 1, pp. 166–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Yang, Q. Hu, Y. Fan, and H. Shen, “Study on the binding of luteolin to bovine serum albumin,” Spectrochimica Acta A: Molecular and Biomolecular Spectroscopy, vol. 69, no. 2, pp. 432–436, 2008. View at Publisher · View at Google Scholar
  44. S. N. Timaseff, “Thermodynamics of protein interactions,” in Proteins of Biological Fluids, H. Peters, Ed., pp. 511–519, Pergamon Press, Oxford, UK, 1972. View at Google Scholar
  45. Clarke's Analysis of Drugs and Poisons, Pharmaceutical Press, 3rd edition, 2005.